Skip to main content
  • Clinical Update

    Goniotomy Makes a Comeback in Adults

    By Rebecca Taylor, Contributing Writer, interviewing Sahar Bedrood, MD, PhD, Shivani S. Kamat, MD, Frini A. Makadia, MD, and Elizabeth A. Martin, MD

    Download PDF

    Goniotomy—long considered a leading surgical option for pediatric glaucoma—has reemerged as a treatment for adult glau­coma, driven primarily by advances in minimally invasive glaucoma surgery (MIGS).1

    “MIGS has exploded on the glauco­ma scene,” said Shivani S. Kamat, MD, at UT Southwestern Medical Center in Dallas. “Traditional surgeries for glau­coma, like trabeculectomy, work well but have a lot of risks associated with them. MIGS has allowed us to offer surgical options that aren’t as risky and can be performed earlier in the disease process, which has been proven helpful in slowing the disease.”

    “We know from historical data that goniotomy works,” said Frini A. Maka­dia, MD, at the Wheaton Eye Clinic in Wheaton, Ill. “These new minimally invasive procedures can be [used] for patients who have gone beyond what drugs or laser can provide but who don’t need a full-blown excisional surgery like a trabeculectomy or tube shunt, which we know come with com­plications.”

    What counts as goniotomy success?

    “Goniotomy treats the trabecular meshwork [TM], the portion of the drainage system where the majority of pathology with glaucoma exists,” said Dr. Kamat. “I consider the procedure a success if I get a 20% to 30% decrease of pressure and I’m able to stop a [glauco­ma] drop or two.” Dr. Makadia noted, “I usually get about a 20% pressure reduction, and patients can usually stop at least one medication.”

    External photo.
    POTENTIAL CANDIDATE. A standalone goniotomy is an option for selected patients, including those with secondary mechanisms like pseudoexfoliation. This image was originally published in the ASRS Retina Image Bank. Jason S. Calhoun. Pseudoexfoliation Syndrome Ring. Retina Image Bank. 2015; Image Number 25759. © The American Society of Retina Specialists.

    Indications, Contraindications

    Sahar Bedrood, MD, PhD, at Advanced Vision Care in Los Angeles, performs goniotomies in patients with moderate or severe open-angle glaucoma (OAG), either as a standalone procedure “or in conjunction with cataract surgery for those intolerant of [glaucoma] drops or needing extra IOP lowering surgically.”

    “The beauty of goniotomy is that it’s very versatile for patients with OAG and even for some with narrow angles who require an IOP-lowering proce­dure and cataract surgery at the same time,” said Dr. Kamat (see “Goniotomy Plus Phacoemulsification”). “It’s very low risk and user-friendly, and it tends to work well—and if it doesn’t, it won’t preclude you from doing other procedures down the line.”

    And even though the procedure can be performed with cataract surgery, Dr. Makadia said, “It’s worthwhile to try a standalone goniotomy regardless of cataract status if patients have uncon­trolled glaucoma or a secondary mech­anism like pigment dispersion, pseudo­exfoliation, steroid-induced glaucoma, or uveitic glaucoma.” Other indications include cases when “glaucoma is pro­gressing but there’s time to attempt a goniotomy before proceeding to a tube shunt or trabeculectomy,” she said.

    Contraindications. Potential contra­indications include Sturge-Weber syn­drome and thyroid eye disease, said Dr. Bedrood. In both instances, pressure creates resistance beyond the Schlemm canal, because the goniotomy may not lower pressure enough.

    If someone has a mild peripheral anterior synechia, you can remove it intraoperatively before goniotomy, added Dr. Kamat, “but for wide areas of scarring, typically you would avoid goniotomy.”

    Goniotomy Plus Phacoemulsification

    When the Kahook Dual Blade and BANG procedures are combined with cat­aract surgery, they are known as phaco-KDB and phaco-BANG. Does either approach bring better results than its standalone iteration?

    “I think they’re pretty similar in terms of outcomes,” said Dr. Martin. “We did a study on all our phaco-BANGs in mild, moderate, and severe glaucoma, and a good number of them had excellent [pressure] reduction” that was statis­tically significant.1 Dr. Martin added, “I could delay the trabeculectomy or not even do one, which was exciting.”

    With regard to phaco-KDB, a study of 197 eyes compared phaco-KDB to standalone KDB.2 At one year, the mean IOP in the phaco-KDB group had dropped from 16.7 mm Hg to 13.8 mm Hg, versus 20.4 mm Hg to 14.1 mm Hg for those in the KDB-only group. Those treated with phaco-KDB reduced their medication burden from 1.9 to 1.5 medications, while the KDB-only group went from 3.1 to 2.3 medications.

    ___________________________

    1 Townsend J et al. Invest Ophthalmol Vis Sci. 2021;62(8):3431.

    2 Sieck EG et al. Ophthalmol Glaucoma. 2018;1(1):75-81.

    Comparing Instrumentation

    Devices to open the TM include the microvitreoretinal (MVR) blade; the Trabectome (MicroSurgical Technolo­gy), used to perform trabeculectomy; the iTrack (Nova Eye Medical) canaloplas­ty microcatheter, used to enlarge the Schlemm canal; and the OMNI trabec­ulotomy system (OMNI Surgical).2

    But as Drs. Makadia and Kamat not­ed, the Kahook Dual Blade (New World Medical) has become an increasingly popular MIGS device. “I mostly use the Kahook; it’s a small, curved-angle blade that’s easy to get into the angle and ma­nipulate,” Dr. Makadia said. With paral­lel blades, a ramp, and a 230-μm–wide footplate that sits in the 250-μm–wide Schlemm canal, the Kahook can lift and cut the TM in a single pass.1

    “I typically use the Kahook to per­form a goniotomy; it glides through the tissue very easily,” said Dr. Kamat. “The Trabectome has other features, like ablating the tissue as it’s cutting to help prevent bleeding, but that creates scar tissue, which isn’t always favorable.”

    “Goniotomy has its own nuances but can be quickly learned,” added Dr. Makadia. “I’ve had a few comprehen­sive ophthalmologists ask about new procedures, and I’ve always encouraged them to try the Kahook. It’s something they felt comfortable with very quickly.”

    Another option, known as BANG (for bent ab interno needle goniectomy), is also gaining traction. It is decidedly low tech by design: as with the original pediatric technique, the surgeon uses a simple bent hypodermic needle. (Of note, goniotomy can be variously—and confusingly—referred to as goniectomy, excisional goniotomy, or even trabe­culectomy in some literature.3)

    Surgical Insights

    Visualization and access. Dr. Kamat’s No. 1 tip for any MIGS procedure: “Make sure you have a good view, using gonioscopy, to see the drainage angle.”

    Using the Kahook. With the Ka­hook, “I magnify down about five-fold compared to cataract surgery and turn the patient’s head 35 degrees and the microscope 30 degrees toward me for good access to the angle,” said Dr. Bedrood. As she’s cutting, she watches to confirm that the blade isn’t cutting inferiorly into the ciliary body or superiorly into the cornea, she said. “The second you meet resistance, you’re too far into either the TM or the ciliary body space. Seeing the nice white sheen of Schlemm canal means I’ve taken off the right layer of TM.”

    “Depending on how much pressure-lowering I’m hoping to achieve and what the pathology is,” said Dr. Makadia, “I can sometimes safely incise up to 30% to 40% of the angle with good visibility.”

    Viscoelastic. “Make sure you use enough viscoelastic to keep the anterior chamber and IOP stable, because that will help tamponade any bleeding,” said Dr. Kamat. “You don’t want the eye to be very firm, which can close off Schlemm canal, but a ‘soft’ eye compromises the view with a lot of striae in the cornea.”

    Using the BANG technique. Eliz­abeth A. Martin, MD, at the Indiana University School of Medicine in Indi­anapolis, said she prefers BANG. “I was doing some Kahooks and a lot of GATT [goniotomy-assisted transluminal tra­beculotomies] with the iTrack and then OMNI,” Dr. Martin said. “The BANG is like a ‘poor man’s Kahook’ because it gives me very similar feedback [while cutting] and glides along very nicely.”

    Needle plus viscoelastic. “I bend a short, 25-gauge needle and use a heavy viscoelastic,” Dr. Martin said. She uses .5-inch needles, because typical 1.5-inch, 25-gauge needles “can create un­safe torque in the eye, since the anterior chamber is only one centimeter.” While each single-use Kahook device costs about $250, she added, the needle costs a few dollars, so it’s cost-effective and more easily transported to the develop­ing world.

    A note on terminology. Even though BANG is often called a “goniectomy,” Dr. Martin considers it to be a goniot­omy because she’s not taking a strip of tissue away.

    More Thoughts on Patient Selection

    Kahook versus BANG. Is BANG a better choice than the Kahook for certain cases? “They can be used interchange­ably,” Dr. Martin said, “although certain angles have a bit more scarring, and because the [hypodermic] needle is sharper than the Kahook, it’s a little easier to get into the tissue.” Results of a recent study found that BANG was comparable to high-tech goniotomy in lowering IOP and reducing medication burden: 73% of participants had a drop of 20% or greater in IOP, and 73% were able to come off of one or more glauco­ma medications.4

    Disease stage. “In early and mod­erate glaucoma in adults, the drainage is still salvageable,” said Dr. Bedrood. “I typically don’t do goniotomy in early glaucoma when there’s still a chance to revive the TM with bypass stents, canaloplasty, or selective laser trabec­uloplasty. There’s a lot we don’t know about glaucoma, so we don’t want to take functional tissue away.”

    Tissue-sparing considerations. For her part, Dr. Martin said, “In mild glaucoma I’ve moved to [doing] more tissue-sparing angle-based surgery, such as stenting, where the TM still has some function. But in moderate and severe glaucoma, I’ve moved toward removing that TM because it’s dead weight.”

    Postoperative Expectations

    A micro-hyphema is the most common goniotomy complication, and it usually clears by week one, said Dr. Makadia. “If I expect a lot of postoperative bleeding, I put a sterile air bubble in the anterior chamber, which usually tam­ponades the bleeding.”

    Following surgery, Dr. Bedrood said that she puts patients on an antibiotic and prednisone four times a day, “which I taper up or down according to how much inflammation they have.”

    “Patients may have [transient] blurry vision after post-op week one,” added Dr. Makadia, “but goniotomy is worthwhile from a glaucoma standpoint and generally won’t have a long-term impact on final vision.”

    A post-op IOP spike is also common due to steroid exposure, Dr. Makadia said. “I keep my patients on their glaucoma medications until post-op month one, and if [they’re] below their goal pressure, I’ll put them on a trial of stopping one or two medications.”

    ___________________________

    1 Dorairaj S et al. J Curr Glaucoma Prac. 2022;16(1):59-64.

    2 Ammar DA et al. Clin Ophthalmol. 2020;14:3519-3525.

    3 Habash AA, Albuainain A. Sci Rep. 2021:11:10660.

    4 Shute T et al. J Ophthalmic Vis Res. 2022;17(2):170-175.

    ___________________________

    Dr. Bedrood is a glaucoma and cataract specialist at Advanced Vision Care in Los Angeles. Relevant financial disclosures: None.

    Dr. Kamat is a glaucoma specialist and assistant professor of ophthalmology at UT Southwestern Medical Center in Dallas. Relevant financial disclosures: New World Medical: L.

    Dr. Makadia is a glaucoma specialist at the Wheaton Eye Clinic in Wheaton, Ill. Relevant financial disclosures: None.

    Dr. Martin is a glaucoma specialist and assistant professor of clinical ophthalmology at theIndiana University School of Medicine in Indianapolis. Relevant financial disclosures: None.

    For full disclosures and the disclosure key, see below.

    Full Financial Disclosures

    Dr. Bedrood Allergan: C,L; Glaukos: C,L; Théa Laboratorie; C; Ocular Therapeutix: C.

    Dr. Kamat Alcon: L; Allergan: C,L; Glaukos: L; New World Medical: L.

    Dr. Makadia None.

    Dr. Martin None.

    Disclosure Category

    Code

    Description

    Consultant/Advisor C Consultant fee, paid advisory boards, or fees for attending a meeting.
    Employee E Hired to work for compensation or received a W2 from a company.
    Employee, executive role EE Hired to work in an executive role for compensation or received a W2 from a company.
    Owner of company EO Ownership or controlling interest in a company, other than stock.
    Independent contractor I Contracted work, including contracted research.
    Lecture fees/Speakers bureau L Lecture fees or honoraria, travel fees or reimbursements when speaking at the invitation of a commercial company.
    Patents/Royalty P Beneficiary of patents and/or royalties for intellectual property.
    Equity/Stock/Stock options holder, private corporation PS Equity ownership, stock and/or stock options in privately owned firms, excluding mutual funds.
    Grant support S Grant support or other financial support from all sources, including research support from government agencies (e.g., NIH), foundations, device manufacturers, and\or pharmaceutical companies. Research funding should be disclosed by the principal or named investigator even if your institution receives the grant and manages the funds.
    Stock options, public or private corporation SO Stock options in a public or private company.
    Equity/Stock holder, public corporation US Equity ownership or stock in publicly traded firms, excluding mutual funds (listed on the stock exchange).